VIENNA, AUSTRIA -- (Marketwire) -- 04/15/10 -- On the occasion of the 2010 edition of the European Association for the Study of the Liver (EASL) conference, Echosens, a pioneer and major player in the field of non-invasive hepatology diagnosis, introduces its new research and development focus with the launching of the latest addition to the Echosens product line, the FibroScan® 402.Facilitating access to quantification of hepatic fibrosisIn creating the FibroScan® 502 and its dedicated probes and commercializing the product since 2004, Echosens opened a new market for medical hepatology devices. This first version of the Fibroscan® answered the needs
More...
More...